Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Drug Delivery

• Publication date

  2013-01-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.3109/10717544.2012.752421PMID 23311653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for Valsartan

  2012cited by this paper
• Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.

  2012cited by this paper
• Ondansetron loaded pectin based microspheres for nasal administration: In vitro and in vivo studies

  2012cited by this paper
• Structural characterization of novel phospholipid lipid nanoparticles for controlled drug delivery.

  2011cited by this paper
• Production & stability of stavudine solid lipid nanoparticles--from lab to industrial scale.

  2011cited by this paper
• Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route

  2011cited by this paper
• Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting

  2011cited by this paper
• Surfactant effects on the physical characteristics of Amphotericin B-containing nanostructured lipid carriers

  2010cited by this paper
• Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability

  2010cited by this paper
• Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology

  2010cited by this paper
• Current management of Parkinson's disease.

  2010cited by this paper
• Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.

  2009cited by this paper
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009influential reference
• Formulation and evaluation of nasal mucoadhesive microspheres of Sumatriptan succinate

  2009cited by this paper
• Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System

  2009cited by this paper
• Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.

  2007cited by this paper
• Parkinson's Disease and Anaesthesia

  2007cited by this paper
• Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation.

  2006cited by this paper
• Freeze-drying of nanoparticles: formulation, process and storage considerations.

  2006influential reference
• What has been learnt from study of dopamine receptors in Parkinson's disease?

  2006cited by this paper
• Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.

  2004cited by this paper
• Physico-chemical stability of colloidal lipid particles.

  2003cited by this paper
• Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique.

  2003cited by this paper
• Solid lipid nanoparticles: production, characterization and applications.

  2001cited by this paper
• Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys.

  2000influential reference
• Transport of drugs from the nasal cavity to the central nervous system.

  2000influential reference
• Psychotropic and neurotropic activity

  1997cited by this paper
• Kinetics of drug release from hydrogel matrices

  1985cited by this paper

• Intranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model.

  2026cites this paper
• Poly(2-ethyl-2-oxazoline)-coated solid lipid nanoparticles to enhance ocular delivery of timolol maleate: Design, fabrication and in vitro-in vivo evaluations

  2026cites this paper
• Intranasal Delivery of Natural Compounds: A Promising approach for Parkinson’s Disease therapy

  2026cites this paper
• Unlocking the potential of lipid-based nanoparticles for intranasal drug delivery in Parkinson's disease.

  2026cites this paper
• QUALITY-BY-DESIGN DEVELOPMENT OF CURCUMIN-LOADED NANOSUSPENSION FOR ENHANCED SOLUBILITY AND SOLIDIFICATION INTO ORAL THIN FILMS

  2026cites this paper
• Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives

  2025cites this paper
• Chitosan-coated nanostructured lipid carriers of amantadine for nose-to-brain delivery: formulation optimization, in vitro-ex vivo characterization, and in vivo anti-parkinsonism assessment.

  2025cites this paper
• Hydrophobic ion pairing–loaded SNEDDS for leuprolide acetate: in vitro feasibility for enhanced lipophilicity, acidic dissolution control, and MDCK permeability

  2025cites this paper
• Formulation and Optimisation of Mucoadhesive Nasal Powder of Celecoxib for Management of Pain Associated with Osteoarthritis

  2025cites this paper
• Nose-to-Brain Targeting of Pregabalin via Phospholipid Complex Nanoparticles for Facilitated Epilepsy Therapy: Design, Optimization and In vitro-In vivo Evaluations

  2025cites this paper
• Intranasal delivery of drug-loaded polymeric nanomicelles for brain targeting: a comprehensive review

  2025influential citation
• Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease

  2024cites this paper
• Lipid-based nanoparticles for drug delivery in Parkinson’s disease

  2024cites this paper
• The synthesis, application and therapeutic perspectives of medicinal plants-based solid lipid nanoparticles: a comprehensive review

  2024cites this paper
• Lipid-based nanoparticles: innovations in ocular drug delivery

  2024cites this paper
• Development, characterization and pharmacokinetic evaluation of selegiline HCl loaded cubosomal thermoreversible mucoadhesive gel for nose to brain delivery

  2024cites this paper
• Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.

  2024cites this paper
• Research progress on intranasal treatment for Parkinson's disease

  2024cites this paper
• Continuous preparation of sustained release vildagliptin nanoparticles using tubular microreactor approach

  2024cites this paper
• A review on lipid-based nanocarriers mimicking chylomicron and their potential in drug delivery and targeting infectious and cancerous diseases

  2023cites this paper
• Single and Multitarget Systems for Drug Delivery and Detection: Up-to-Date Strategies for Brain Disorders

  2023cites this paper
• Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: Nanodelivery and enriched environment.

  2023cites this paper
• Design and evaluations of a nanostructured lipid carrier loaded with dopamine hydrochloride for intranasal bypass drug delivery in Parkinson’s disease

  2023cites this paper
• Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review.

  2023cites this paper
• Formulation and Evaluation of Butenafine Hydrochloride-Incorporated Solid Lipid Nanoparticles as Novel Excipients for the Treatment of Superficial Fungal Infections

  2023cites this paper
• SOLID LIPID NANOPARTILCES: MODERN PROGRESS IN NOSE-TO-BRAIN TRANSDUCTION

  2023cites this paper
• Synthesis and characterization of chemical engineered PLGA nanosphere: Triggering mechanism of Catechol-O-methyltransferase inhibition on in vivo neurodegeneration.

  2023cites this paper
• Arginine-Rich Cell-Penetrating Peptide-Mediated Transduction of Mouse Nasal Cells with FOXP3 Protein Alleviates Allergic Rhinitis

  2023cites this paper
• Therapeutic potential of Lipid Nanosystems for the treatment of Parkinson's disease: an updated review.

  2023cites this paper
• Nanotechnology-empowered therapeutics targeting neurodegenerative diseases.

  2023cites this paper
• Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review.

  2023cites this paper
• Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease.

  2023cites this paper
• Quality-by-design based fabrication of febuxostat-loaded nanoemulsion: Statistical optimization, characterizations, permeability, and bioavailability studies

  2023cites this paper
• Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery

  2022cites this paper
• Theoretical and Applied Concepts of Nanocarriers for the Treatment of Parkinson's Diseases

  2022cites this paper
• Nanotherapeutics a promising approach for treatment of Parkinson’s disease

  2022cites this paper
• A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: A systematic review

  2022cites this paper
• Solid lipid nanoparticles (slns): Advancements in modification strategies toward drug delivery vehicle.

  2022cites this paper
• Evaluation of Porous Honeycomb-Shaped CuO/CeO2 Catalyst in Vapour Phase Glycerol Reforming for Sustainable Hydrogen Production

  2022cites this paper
• Neuroprotection by resveratrol: A review on brain delivery strategies for Alzheimer’s and Parkinson’s disease

  2022cites this paper
• Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy

  2022cites this paper
• Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date

  2022cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier

  2021cites this paper
• From the nose to the brain, nanomedicine drug delivery

  2021cites this paper
• Characterization and Systemic Delivery of Dibenzoylmethane via the Intranasal Route

  2021cites this paper
• Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs

  2021cites this paper
• Microemulsion as a promising carrier for nose to brain delivery: journey since last decade

  2021cites this paper
• Past Decade Work Done on Cubosomes and its Factorial Design: A Fast Track Information for Researchers

  2021cites this paper
• Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: toxicological effect of surface charge on human neuronal cells.

  2021cites this paper
• A Recent Update: Solid Lipid Nanoparticles for Effective Drug Delivery

  2021cites this paper
• Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB

  2021cites this paper
• Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies

  2021cites this paper
• Strategies for enhanced direct nose-to-brain drug delivery

  2021cites this paper
• Surface modification of nanocarriers as a strategy to enhance the direct nose-to-brain drug delivery

  2021cites this paper
• Applications of nose-to-brain delivery in nanodiagnosis and nanotherapy of neurodegenerative disorders

  2021cites this paper
• Nanoparticles for direct nose-to-brain drug delivery: Implications of targeting approaches

  2021cites this paper
• Recent advancement and development in nanoneurology

  2021cites this paper
• Nanotechnological advances in direct nose-to-brain drug delivery for neurodegenerative disorders and other neuroailments

  2021cites this paper
• Potential applications of nanomedicine for treating Parkinson's disease

  2021cites this paper
• Design and development of surface modified epigallocatechin 3-gallate NanoCubogel for localized delivery to oral submucous fibrosis therapy

  2021cites this paper
• Parkinson's disease

  2021cites this paper
• Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders

  2021cites this paper
• Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood-Brain Barrier Transmitters.

  2021cites this paper
• 22 factorial design-based biocompatible microneedle arrays containing artemether co-loaded with lumefantrine nanoparticles for transepidermal delivery

  2020cites this paper
• Solid Lipid Nanoparticles

  2020cites this paper
• Improved brain pharmacokinetics following intranasal administration of N,N,N-trimethyl chitosan tailored mucoadhesive NLCs

  2020cites this paper
• Effects of haloperidol inhalation on MK-801- and memantine-induced locomotion in mice

  2020cites this paper
• Development and Evaluation of Docetaxel-Phospholipid Complex Loaded Self-Microemulsifying Drug Delivery System: Optimization and In Vitro/Ex Vivo Studies

  2020cites this paper
• Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management

  2020cites this paper
• Development of tamoxifen-loaded surface-modified nanostructured lipid carrier using experimental design: in vitro and ex vivo characterisation.

  2020cites this paper
• Development and evaluation of TPGS/PVA-based nanosuspension for enhancing dissolution and oral bioavailability of ticagrelor.

  2020cites this paper
• Non-Invasive Strategies for Nose-to-Brain Drug Delivery

  2020cites this paper
• Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: in vitro and ex vivo evaluation of efficacy and safety.

  2020cites this paper
• Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

  2019cites this paper
• Nanotechnology-Mediated Nose-to-Brain Drug Delivery for Neurodegenerative Disorders

  2019cites this paper
• SYNTHESIS, IN-SILICO PHYSICOCHEMICAL PROPERTIES AND ANTIMICROBIAL STUDIES OF PYRAZOLINE LOADED NANOPARTICLES

  2019cites this paper
• Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson's disease: From preclinical to translational studies.

  2019cites this paper
• α-Helical cell-penetrating peptide-mediated nasal delivery of resveratrol for inhibition of epithelial-to-mesenchymal transition.

  2019cites this paper
• Intranasal Drug Delivery into Mouse Nasal Mucosa and Brain Utilizing Arginine-Rich Cell-Penetrating Peptide-Mediated Protein Transduction

  2019cites this paper
• Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer’s disease using Box-Behnken design

  2019cites this paper
• Nanodelivery of therapeutic agents in Parkinson's disease.

  2019cites this paper
• Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice.

  2019cites this paper
• Targeted Therapeutic Nanoparticles for Cancer and Other Human Diseases

  2018cites this paper
• Polysorbate 80 coated crosslinked chitosan nanoparticles of ropinirole hydrochloride for brain targeting

  2018cites this paper
• Solid Lipid Nanoparticles: A Modern Approach for the Treatment of Neurodegenerative Diseases

  2018cites this paper
• Current development of nanocarrier delivery systems for Parkinson's disease pharmacotherapy

  2018cites this paper
• Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease

  2018cites this paper
• Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders

  2018cites this paper
• Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment

  2018cites this paper
• Evaluation of intranasal delivery route of drug administration for brain targeting.

  2018cites this paper
• N,N,N‑trimethyl chitosan modified flaxseed oil based mucoadhesive neuronanoemulsions for direct nose to brain drug delivery.

  2018cites this paper
• A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation

  2018cites this paper
• Nanotechnology Based Approaches for Neurodegenerative Disorders: Diagnosis and Treatment

  2017cites this paper
• Scope of Lipid Nanoparticles in Neuroscience: Impact on the Treatment of Neurodegenerative Diseases.

  2017cites this paper
• Lipid Nanoparticles for Nasal/Intranasal Drug Delivery.

  2017cites this paper
• Ropinirole-dextran sulfate nanoplex for nasal administration against Parkinson’s disease: in silico molecular modeling and in vitro–ex vivo evaluation

  2017influential citation
• Intranasal Delivery of Nano Neurotherapeutics: A Meta Opinion

  2017cites this paper
• Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.

  2017cites this paper
• Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review

  2016cites this paper